UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 26 filers reported holding UROVANT SCIENCES LTD in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $8,456,000 | -42.6% | 917,094 | -3.5% | 0.02% | -30.6% |
| Q4 2019 | $14,735,000 | +59.6% | 950,000 | -2.6% | 0.04% | +56.5% |
| Q3 2019 | $9,233,000 | +16.7% | 975,000 | -2.5% | 0.02% | +15.0% |
| Q2 2019 | $7,910,000 | -43.2% | 1,000,000 | -27.8% | 0.02% | -42.9% |
| Q1 2019 | $13,919,000 | +52.5% | 1,385,000 | 0.0% | 0.04% | +40.0% |
| Q4 2018 | $9,127,000 | -37.4% | 1,385,000 | +14.0% | 0.02% | -24.2% |
| Q3 2018 | $14,580,000 | – | 1,215,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|